<DOC>
	<DOCNO>NCT01343160</DOCNO>
	<brief_summary>Generate clinical data support use GORE® VIABIL® Biliary Endoprosthesis endoscopic percutaneous treatment benign biliary stricture .</brief_summary>
	<brief_title>Multicenter Study Removable GORE VIABIL® Biliary Endoprosthesis Treatment Benign Biliary Strictures</brief_title>
	<detailed_description>Primary outcome measure patency follow visit .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Cholestasis</mesh_term>
	<criteria>Subject diagnose treatable benign biliary stricture necessitates need implantation biliary endoprosthesis Subject ≥18 year age Subject able comply study protocol followup requirement Written inform consent obtain use Investigational Review Board ( IRB ) /Ethics Committee ( EC ) approve consent form Subject anatomy ruling cover self expand metal stent use ( e.g . hilar region ) Treatment stricture would require placement cover biliary endoprosthesis within previously place bare metal stent The subject malignant biliary disease Subject know pregnancy Participated protocol involve investigational drug device within 90 day prior entry study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>